Drug Shortage Report for MANNITOL INJECTION USP

Last updated on 2020-04-22 History
Report ID 76861
Drug Identification Number 00038024
Brand name MANNITOL INJECTION USP
Common or Proper name Mannitol Injection USP
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) MANNITOL
Strength(s) 250MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 25 x 50mL GVL
ATC code B05BC
ATC description I.V. SOLUTIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-07-02
Estimated end date
Actual end date 2020-04-21
Shortage status Resolved
Updated date 2020-04-22
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v29 2020-04-22 English Compare
v28 2020-04-21 French Compare
v27 2020-04-21 English Compare
v26 2020-04-21 French Compare
v25 2020-04-21 English Compare
v24 2020-04-15 French Compare
v23 2020-04-15 English Compare
v22 2020-02-12 French Compare
v21 2020-02-12 English Compare
v20 2020-01-22 French Compare
v19 2020-01-22 English Compare
v18 2019-11-08 French Compare
v17 2019-11-08 English Compare
v16 2019-08-26 French Compare
v15 2019-08-26 English Compare
v14 2019-07-03 French Compare
v13 2019-07-03 English Compare
v12 2019-07-03 English Compare
v11 2019-05-26 English Compare
v10 2019-05-17 French Compare

Showing 1 to 20 of 29